Does CJC-1295/Ipamorelin Raise Fasting Glucose and HbA1c?

No published study has tracked fasting blood glucose or HbA1c in people taking CJC-1295 with ipamorelin for three months, so no one can promise what your numbers will do. Studies of related drugs that raise growth hormone show they can make the body less responsive to insulin, and some raised fasting glucose and HbA1c. Get both tested before you start CJC-1295 and ipamorelin, then again near the end of three months, so your clinical team can see what changed for you.

Has anyone measured blood sugar on CJC-1295 and ipamorelin?

Not for the combination over three months. The human research on CJC-1295 consists of early dosing studies in healthy adults that tracked hormone levels. There are no controlled studies of results like body changes, according to a 2026 endocrinology review of growth hormone peptides.

Ipamorelin's human research is also early. In the same review's summary, an early study in healthy adults found it produced a clear rise in growth hormone without significantly affecting other pituitary or adrenal hormones. It was also tested in people recovering from bowel surgery.

The main CJC-1295 trials ran 28 and 49 days in healthy adults aged 21 to 61. That is shorter than a three-month course, and their published summary does not report glucose results. No serious adverse reactions were reported.

Some pages say glucose "normalizes" on CJC-1295 and ipamorelin. None of the research behind this article shows that, so treat it as a claim, not a finding.

Why would a growth hormone peptide raise blood sugar?

Higher growth hormone raises IGF-1, a hormone your liver makes in response to growth hormone. Higher IGF-1 can make your body less responsive to insulin, which can push blood sugar up, according to a review of growth hormone secretagogues (drugs that prompt your body to release growth hormone). Doctors call this lower insulin sensitivity.

The table below compares related drugs, not CJC-1295 and ipamorelin. Each row is a different drug, so none of these results can be assumed for CJC-1295 or ipamorelin.

In these studies, effects on blood sugar ranged from barely any change to clear rises in fasting glucose and HbA1c. Results depended on the drug, the dose and how long people took it. Sometimes insulin moved before glucose did, so a normal glucose reading doesn't tell you everything.

What could three months on CJC-1295 and ipamorelin do to my HbA1c?

HbA1c is a blood test that reflects your average blood sugar over roughly the past two to three months. A three-month course is about long enough for any shift to show up in it.

FDA has said it is concerned that ipamorelin could carry blood sugar risks like those of approved growth hormone products, including glucose intolerance and diabetes. FDA also said it did not find enough data to rule this out.

Here is the case for this pair. CJC-1295 and ipamorelin prompt your own growth hormone in pulses instead of giving you a constant dose. A review of growth hormone secretagogues says this pulsing stays under your body's own feedback controls, which may keep growth hormone from climbing too high.

In one CJC-1295 study in healthy adults, IGF-1 rose an average of 44% a week after an injection, and it stayed within the normal range for everyone. That was the long-acting version with DAC, and the study did not track HbA1c.

Your result depends on your dose, your starting blood sugar and your body. Your own test results tell you more than any study average.

What blood tests should I get before and during CJC-1295 and ipamorelin?

• Before you start: get a fasting glucose and an HbA1c. A 2026 endocrinology review of growth hormone peptides says both are worth checking whichever peptide you use.
• Near the end of three months: recheck both, when HbA1c has had time to reflect any change. Your clinical team sets the timing.
• If you already have high blood sugar or prediabetes: tell your clinical team before you start. Lower insulin sensitivity is the main blood sugar concern with this drug family, according to the secretagogue review.
• Beyond blood sugar: FDA has identified serious side effects in people who used CJC-1295, including a faster heart rate and a reaction in which blood vessels widen throughout the body. Ask your clinical team what to watch for.
• Planning your tests: our clinical team can check whether CJC-1295 and ipamorelin fit your goal, and can plan your blood tests around your three months.

You want the lean, energetic results without guessing what's happening to your blood sugar. Take the quiz, and our clinical team will look at whether CJC-1295 and ipamorelin fit your goal and how to check your numbers along the way.